AFJK

Aimei Health Technology Co Ltd

Exchange: NASDAQSector: IndustrialsIndustry: Shell Companies

Aimei Health Technology Co Ltd

Did you know?

Carries 8.1x more debt than cash on its balance sheet.

Current Price

$46.18

+5.68%

Profile

Valuation (TTM)

Market Cap$282.70M

P/E201.10

EV—

P/B—

Shares Out6.12M

P/Sales—

Revenue$0.00

EV/EBITDA202.28

Aimei Health Technology Co Ltd (AFJK) Financial Statements

AFJK Financial Data

EBITDA$1.41M

Revenue (TTM)$0.00

Gross Profit (TTM)$0.00

Gross Margin—

Operating Margin—

ROE—

ROA1.90%

Debt/Equity—

Current Ratio0.04

FCF$-672289.00

FCF Yield-0.24%

Piotroski F-Score—

Rev/Share (TTM)—

50-Day MA$34.98

200-Day MA$27.11

Shares Outstanding0.01B

AFJK Computed Insights

FCF$-672289.00

FCF Growth Rate—

EPS Growth (CAGR)—

WACC10.00%

Income Statement

Balance Sheet

Cash Flow Statement

AFJK Financial Statements & Data

Aimei Health Technology Co Ltd (AFJK) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of Aimei Health Technology Co Ltd's financial performance and position as a Industrials company.

Trailing twelve-month (TTM) revenue is $0.00. Gross profit (TTM) is $0.00. EBITDA is $1.41M. Earnings per share (EPS) is $0.28. The P/E ratio is 201.10. Market capitalization is $282.70M.

Free cash flow (FCF) is $-672289.00. Weighted average cost of capital (WACC) is 10.00%.

Historical revenue data covers 1 years from FY24 to FY24. Net income history spans 1 years. Free cash flow and capital expenditure data spans 1 years. GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.

Use Aimei Health Technology Co Ltd's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.